Influenza surveillance in <scp>E</scp>urope: comparing intensity levels calculated using the moving epidemic method
Tomás Vega, Caroline Brown, Lisa Domegan(Health Service Executive), Joël Mossong(Luxembourg Institute of Health), Julien Beauté(European Centre for Disease Prevention and Control), Amparo Larrauri(Instituto de Salud Carlos III), Rita Born(Federal Office of Public Health), Pernille Jorgensen(World Health Organization Regional Office for Europe), Raúl Ortíz de Lejarazu(Instituto de Estudios de Ciencias de la Salud de Castilla y León), Jens Nielsen(Statens Serum Institut), José Eugenio Lozano Alonso, René Snacken, T J Meerhoff(Radboud University Nijmegen)
Cited by 124
Related Papers
Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases
|PLoS Medicine|2008|3.2k
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
|Critical Care|2009|382
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
|PLoS Medicine|2011|303
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008
|Eurosurveillance|2008|286